Pluristem Therapeutics
Pluristem Therapeutics's email is info@pluristem.com
and
Pluristem Therapeutics's phone number is +972-74-710-8600
.
Pluristem Therapeutics is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preecla...
read more
Pluristem Therapeutics is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product. The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals.
show less
Website | pluristem.com | |
Industry | Biotechnology | |
Location | Haifa, Hefa, Israel | |
Employees | 134 | |
Founded | 2003 |
HQ | MATAM Advanced Technology Park Building #5 | |
Phone | +972-74-710-8600 | |
info@pluristem.com | ||
Funding | 162,494,975 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | pluristem.com | |
Industry | Biotechnology | |
Location | Haifa, Hefa, Israel | |
Employees | 134 | |
Founded | 2003 | |
linkedin.com/company/pluristem-therapeutics | ||
HQ | MATAM Advanced Technology Park Building #5 | |
Phone | +972-74-710-8600 | |
info@pluristem.com | ||
Funding | 162,494,975 USD |
Email Patterns for Pluristem Therapeutics
Top Competitors for Pluristem Therapeutics
Pluristem Therapeutics Questions
Where are Pluristem Therapeutics's headquarters?
Pluristem Therapeutics's headquarters are in MATAM Advanced Technology Park Building #5
What is Pluristem Therapeutics's phone number?
Pluristem Therapeutics's phone number is +972-74-710-8600
What is Pluristem Therapeutics's official website?
Pluristem Therapeutics's website is pluristem.com
How many employees are working in Pluristem Therapeutics right now?
Pluristem Therapeutics has
134 employees.
View the Email and Phone Numbers for all 134 working at Pluristem Therapeutics.
What is Pluristem Therapeutics's industry?
Pluristem Therapeutics's industry is
Biotechnology
Who are Pluristem Therapeutics's top competitors?
Pluristem Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Pluristem Therapeutics's email address?
Pluristem Therapeutics's email address is info@pluristem.com
What are Pluristem Therapeutics's categories?
Pluristem Therapeutics's categories are 3D Technology, Biotechnology, Therapeutics
What is Pluristem Therapeutics's location?
Pluristem Therapeutics's location is
Haifa, Hefa, Israel
When was Pluristem Therapeutics's founded?
Pluristem Therapeutics's founding year is 2003
What is Pluristem Therapeutics's funding?
Pluristem Therapeutics's funding is 162,494,975 USD
What is Pluristem Therapeutics's current status?
Pluristem Therapeutics's current status is ipo
Top Pluristem Therapeutics Employees
Cra
elittner1@yahoo.com
+1216-392-0978
Chief Medical Officer
nitsan.halevy@gmail.com
+97254-621-1092
Director Of Biostatistics
eli.eyal@teva.co.il
+97254-888-6602
Hr Bp And O.D Manager
nilis@pluristem.com
+97274-710-7233
Human Resources Administrator
zoyka86@gmail.com
+97274-710-7179
Consultant
glalazar@rockefeller.edu
+1646-305-4838
Vice President Of Business Development
yaron@cherny.co.il
+1954-753-8588